School of Pharmaceutical Sciences, Universiti Sains Malaysia

Researcher Profile

Dzul

DZUL AZRI 270917

 

Name of Member

:

DZUL AZRI MOHAMED NOOR

Researcher ID/ ORCID no./ Google scholar link

:

-

Room/location, phone

:

J01 Room 109, School of Pharmaceutical Sciences.

Tel : 604-6533888 Ext. 2205

Email address

:

dzulazri@usm.my

Qualification

:

B.Pharm (Hons) (USM)

MPharm (Clin.Pharm) (USM) 

PhD (Nottingham, UK)

Research Area

:

Pharmacogenomics, Clinical Pharmacy, Epigenetics, Oncology

Projects (ongoing/ completed)

:

1. Clopidogrel pharmacogenomics (completed)

2. HLA genotyping and Antiepileptic drug-induced SCAR (ongoing)

3. Pharmacogenomics of Carbamazepine Response in epilepsy patient (ongoing)

Publications

:

https://scholar.google.com.my/citations?user=yf18feUAAAAJ&hl=en

 

Fatima

FATIMATUZZAHRA 270917

Name of Member

:

FATIMATUZZAHRA' ABDUL AZIZ

Researcher ID/ ORCID no./ Google scholar link

:

-

Room/location, phone

:

J01 Room 107, School of Pharmaceutical Sciences.

Tel : 604-6533888 Ext. 4088

Email address

:

faa@usm.my

Qualification

:

B.Pharm (Hons) (USM)

MPharm (Clin.Pharm) (USM)

PhD (USM)

Research Area

:

Metabolomics, NMR, Clinical Pharmacy, Nephrology, Traditional & complementary Medicine

Projects (ongoing/ completed)

:

1. Gentamicin Pharmacometabonomic.                                       

2. Macronutrient: anemia

Publications

:

https://scholar.google.com/citations?hl=en&user=nG51_YgAAAAJ

 

Hadzliana

HADZLIANA 270917

Name of Member

:

HADZLIANA ZAINAL

Researcher ID/ ORCID no./ Google scholar link

:

ORCID ID: 0000-0001-6263-4824

Researcher ID: N-7911-2017

Room/location, phone

:

J01 Room 129, School of Pharmaceutical Sciences.

Tel : 604-6532264 Ext. 2264

Email address

:

hadz@usm.my

Qualification

:

B.Pharm (Hons) (USM)

MPharm (Clin.Pharm) (USM) 

PhD (London, UK)

Research Area

:

Clinical Pharmacy, Nephrology, Pharmacometrics, pharmacokinetics (PK)/pharmacodynamic (PD) modelling

Projects (ongoing/ completed)

:

1. Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa

2. Clinical trial of PKPD of mitragynine in Kratom users

3. In vivo study of mitragynine PKPD in brain

4. Evaluation of Gentamicin Population Pharmacokinetic Model for Malaysian Neonates and Infants

Publications

:

https://scholar.google.com/citations?hl=en&user=nG51_YgAAAAJ

 

Aizati

NUR AIZATI 270917

Name of Member

:

NUR AIZATI ATHIRAH DAUD

Researcher ID/ ORCID no./ Google scholar link

:

ORCID ID: 0000-0003-4336-9468

Researcher ID: P-8506-2017

Room/location, phone

:

J01 Room 130, School of Pharmaceutical Sciences.

Tel : 604-6533888 Ext. 2412

Email address

:

aizati@usm.my

Qualification

:

B.Pharm (Hon) (USM)

M. Pharm (Clin. Pharm) (USM)

PhD (Groningen, NL)

Research Area

:

Pharmacogenomics, Genetic association studies, Obstetrics and gynaecology pharmacy, Perinatal mental health

Projects (ongoing/ completed)

:

HLA genotypes and hthe risk of antiepileptic-induced severe cutaneous adverse reaction

Publications

:

https://scholar.google.com/citations?user=PVgs-mMAAAAJ&hl=en

  

Hafzan

 

NUR HAFZAN 270917

Name of Member

:

NUR HAFZAN MD HANAFIAH 

Researcher ID/ ORCID no./ Google scholar link

:

ORCID ID: 0000-0002-6137-0705

Room/location, phone

:

J01 Room 131, School of Pharmaceutical Sciences.

Tel : 604-6533888 Ext. 2413

Email address

:

hafzanhanafiah@usm.my

Qualification

:

B.Pharm (Hon) (USM)

M. Pharm (Clin. Pharm) (USM)

Research Area

:

Pharmacogenomics, Clinical Pharmacy, Oncology, Mental health, Immunization/Vaccination

Projects (ongoing/ completed)

:

-

Publications

:

https://scholar.google.com/citations?view_op=search_authors&hl=en&mauthors=nur+hafzan+md+hanafiah&btnG=

 

Sabariah

SABARIAH NOOR 270917

Name of Member           

:

SABARIAH NOOR HARUN

Researcher ID/ ORCID no./

Google scholar link            

:

Scopus ID: 57189660207

ResearcherID (ISI):E-5102-2012  

ORCID ID: 0000-0001-8476-7425

Room/location, phone   

:

J01 Room 134, School of Pharmaceutical Sciences.

Tel : 604-6533888 Ext. 2414

Email address

:

sabariahnoor@usm.my

Qualification

:

B.Pharm (Hon) (USM)

M. Pharm (Clin. Pharm) (USM)

PhD (Queensland, Australia)

Research Area

:

Pharmacometrics, pharmacokinetics (PK)/pharmacodynamic (PD)

modelling,

disease progression modelling, time-to-event modelling (diabetes, stroke and infectious disease),

Clinical Pharmacy

Projects (ongoing/ completed)                     

:

-

Publications

:

https://scholar.google.com/citations?hl=en&user=BHrXm1YAAAAJ&view_op=list_works&sortby=pubdate

 

Maisharah

SITI MAISHARAH 270917

Name of Member                           

:

SITI MAISHARAH SHEIKH GHADZI                                                                             

Researcher ID/ ORCID no./

Google scholar link   

:

ORCID ID: 0000-0001-8855-8954

Researcher ID: E-5100-2012

Room/location, phone

:

J01 Room 117, School of Pharmaceutical Sciences.

Tel : 604-6533888 Ext. 4585

Email address

:

maisharah@usm.my

Qualification

:

B.Pharm (Hon) (USM)

M. Pharm (Clin. Pharm) (USM)

PhD (Uppsala, Sweden)

Research Area

:

Pharmacometrics, pharmacokinetics (PK)/pharmacodynamic (PD) modelling,

Clinical Pharmacy, disease progression modelling (diabetes, tuberculosis,

stroke, chronic kidney disease), time-to-event modelling

Projects (ongoing/ completed)

:

Pharmacometrics

1. Effect of rifampicin concentration and glucose level on the tuberculosis

treatment outcomes with the incorporation of PKPD modelling and

pharmacogenomics of rifampicin. (2020-current)

2. Time-to-event and disease progression modelling of first-time stroke in

patients with T2DM (2020-current)

3. PKPD modelling of clozapine among schizophrenia patients.

(2019-current)

4. Time-to-event and disease progression modelling of chronic kidney

disease among geriatrics patients with T2DM (2019-current)

5. Time-to-event and disease progression modelling of T2DM to

tuberculosis and tuberculosis outcome in patients with T2DM

(2019-current)

6. Time-to-event and disease progression modelling of T2DM to

tuberculosis and tuberculosis outcome in patients with T2DM

(2019-current)

7. Time-to-event modelling of recurrent stroke in patients with T2DM

(2018-current)

8. Time-to-event and disease progression modelling of diabetic

nephropathy in patients with T2DM (2018-current)

9. Predictive model of diabetes in prediabetics (2018-current)

10. Diabetes disease progression modeling in subjects with impaired

glucose tolerance (2015-2017)

11. Investigation on insulin measurement in glucose provocation studies for

Phase II clinical study (2013-2015)

12. Investigation on best study design in glucose provocation test in Phase

I clinical study (2013-2015)

Clinical

1. KAP towards insulin therapy among children and adolescent with T1DM

(2019-current)

2. Diet quality and association with glycemic control, illness perception and

CVD risk (2017-2019)

3. Effect of diabetes MTAC pharmacist insulin management on HBA1c

(2018-2019)

4. Factors influencing AKURIT-4 treatment outcome in Tuberculosis

(2017-2019)

5. Healthcare providers awareness on the life-threatening drug-drug

interactions (2017-2018)

6. Effectiveness of PCM for closure of PDA in premature infant (2018-2019)

7. Patient’s adherence towards diabetic medication (2011-2012)

8. Barriers on diet and exercise recommendation in patients with T2DM

(2009-2011)

Publications

:

https://scholar.google.com.my/citations?user=UblHa4QAAAAJ&hl=en

 

Mei Lan

TAN MEI LAN 001

Name of Member   

:

TAN MEI LAN

Researcher ID/ ORCID no./

Google scholar link   

:

http://www.researcherid.com/rid/E-3500-2012 ORCID ID: orcid.org/0000-0001-

6565-699X

Room/location, phone   

:

1. J06, School of Pharmaceutical Sciences, USM, Minden, Pulau Pinang

2. Cluster of Lifetsyle Sciences, Advanced Medical and Dental Institute, USM,

SAINS@BERTAM>,

Kepala Batas 13200 Pulau Pinang Tel: 0125831892

Email address

:

tanml@usm.my

Qualification

:

B. Pharm (Hons) (USM)

M. Pharm (Clin Pharm)

PhD (USM)

Research Area

:

Molecular Pharmacology and Toxicology: Drug-drug and drug-herb interactions -

cytochromes,

Pgp and drug transporters and hERG potassium channel;

Cell death mechanisms - autophagy & ER stress); Obesity and ketogenic diet

Projects (ongoing/ completed) 

:

1. Safety and Drug-Herb Interactions Labelling Initiative for Finished Botanical

Products, Integrating Data Science and Experimental Strategies

(Smartfund - 2019-current)

2.The intrinsic roles of Endoplasmic Reticulum (ER) stress sensors in the

mechanism underlying the depressive symptoms in chronic kratom users

(FRGS - 2019-current)

3. The molecular mechanisms of ketone bodies-induced autophagy in human

adipocytes (FRGS-2019-current)

4. Drug-herb interactiosn for finished botanical products

(Short term USM matching grant 2020 - current)

Publications

:

http://www.scopus.com/authid/detail.url?authorId=8431139400

https://scholar.google.com.my/citations?user=4aILPLkAAAAJ&hl=en

 

  • Hits: 5252

School of Pharmaceutical Sciences
11800 Universiti Sains Malaysia, Pulau Pinang, Malaysia.

Tel : . 04-653 3812 | Fax: +604-657 0017

  • Last Modified:
    Isnin 11 November 2024, 12:52:24.